NCT02342847

Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer

Observational Cohort Study of Health-related Quality of Life in Patients Initiating Treatment With Chemotherapy for Metastatic Pancreatic Cancer

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 120 (actual)
• Sponsor: Celgene · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is an observational, post-authorization, prospective follow-up, multi-centre, national study designed to describe the spectrum of health-related quality of life in patients with metastatic pancreatic cancer previously untreated with chemotherapy This study is designed to observe patients treated in routine clinical practice, without the exclusion limitations of a clinical trial. Patients will be enrolled in 7 Spanish sites. In all cases, the decision to treat patients will be performed prior to the decision to include the patient in the study. Given the observational nature of the study, follow-up of patients will be performed according to standard clinical practice of each site.

Conditions

• Pancreatic Neoplasms

Interventions

Type	Name	Description
OTHER	N/A (non-interventional study)

Timeline

• Start date: 2014-12-10
• Primary completion: 2016-11-09
• Completion: 2018-11-16
• First posted: 2015-01-21
• Last updated: 2019-01-25

Locations

12 sites across 1 country: Spain